Search…

    Saved Articles

    You have not yet added any article to your bookmarks.

    Browse

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    Novo Nordisk and Septerna to Collaborate on Oral Medicines for Obesity and Other Diseases

    6 hours ago

    The $2.2 billion deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other cardiometabolic diseases.
    Click here to Read more
    Prev Article
    President Trump has turned the pardon process into the Wild West. What had been a sober legal proceeding increasingly resides in the White House.
    Next Article
    Rory vs. Bryson vs. Scottie: The PGA Championship That’s a Showdown for the Ages

    Related Health Updates:

    Comments (0)

      Leave a Comment